New Medicine - A Comprehensive Information and Consulting Service  
HOME PRODUCTS & SERVICES ORDER/INQUIRY PRESS RELEASES EMPLOYMENT CONTACT US

Future Oncology - Technology, Products, Markets, and Service Opportunities

* Requires Adobe Acrobat Reader

FUTURE ONCOLOGY - TECHNOLOGY, PRODUCTS, MARKETS, AND SERVICE OPPORTUNITIES IN THE CANCER FIELD

FUTURE ONCOLOGY
Volume 7 #12 April 2004


STATE-OF-THE-ART IN THE MANAGEMENT OF CANCER

PANCREATIC CANCER PART III
NOVEL CYTOTOXICS, HORMONE MODULATORS, FORMULATIONS/PRODRUGS AND RELATED AGENTS IN DEVELOPMENT

NOVEL CYTOTOXICS
  • Topoisomerase I Inhibitors
    • DX-8951f
    • DE-310
    • LE-SN38
    • MBT-0312
    • Rubitecan
    • S-CKD602
  • Antimitotics/Spindle Poisons/Cell-Cycle Modulators
    • Cantuzumab mertansine
    • CRx-026
    • DHA-paclitaxel
    • Disorazol E1
    • DJ-927
    • Flavopiridol
    • MBT-0206
    • Mebendazole (MZ)
  • Antimetabolites/Nucleoside Analogs
    • 4'-thio-FAC
    • Clofarabine
    • CYC682
    • OSI-7836
    • Tezacitabine
    • Troxacitabine
  • Antimetabolites/Thymidylate Synthase (TS) Inhibitors/Antifolates
    • AG2037
    • BGC 9331
    • Davanat-1
    • Nolatrexed dihydrochloride
    • Pemetrexed sodium
  • Alkylating Agents/Toxins
    • Glufosfamide
    • Ifosfamide
    • Irofluven

OTHER NOVEL ANTICANCER AGENTS

  • MPC-6827
  • Natural Products/Vitamin Analogs
    • Isoprenoids
    • Perillyl alcohol
    • SR271425
    • Vitamin K2
  • Retinoids
    • AGN193198
  • SDX-102
  • Triapine

DIGESTIVE ENZYMES

HORMONE MODULATORS

RADIOSENSITIZERS/CHEMOSENSITIZERS

  • CoFactor
  • Motexafin Ganolinium
  • O(6)-benzylguanine


LIST OF EXHIBITS

Exhibit 1 - Novel Cytotoxics, Hormone Modulators, Prodrugs/Formulations and Related Agents Evaluated Either Clinically or Preclinically for the Treatment of Pancreatic Cancer


HOME | PRODUCTS & SERVICES | ORDER/INQUIRY | PRESS RELEASES | EMPLOYMENT | CONTACT US

NEW MEDICINE, INC.
PHONE: 949-830-0448   FAX: 949-830-0887